Direct or total bilirubin < . x ULN (unless related to Gilberts or Meulengrachts syndrome); the values must be obtained within  hours prior to randomization
Total bilirubin =< . x ULN; except subjects with known Gilberts syndrome
Total serum bilirubin =< . X ULN (except participants with Gilberts syndrome, who can have a total bilirubin [bili] <  X ULN), performed within  days of treatment initiation
Total bilirubin ?  X ULN (subjects with Gilberts disease can have bilirubin of up to . X ULN)
Total bilirubin: =< . x ULN (in case of known Gilberts syndrome, <  x ULN is allowed) within  weeks of pre-registration
Bilirubin =< . x ULN (=<  x ULN for subjects with Gilberts disease)
Total bilirubin =< . x institutional ULN, unless documented Gilberts syndrome
Serum total bilirubin =<  x ULN (except for patients with Gilberts Syndrome)
Bilirubin =<  unless consistent with Gilberts (total/direct > )
Total bilirubin ? . x ULN OR in subjects with Gilberts syndrome, a total bilirubin ? . x ULN
Total bilirubin =<. x ULN (excepting Gilberts syndrome)
Bilirubin =< . x ULN OR in subjects with Gilberts syndrome, a total bilirubin =< . x ULN
Bilirubin: =< . x ULN (except for subjects with Gilberts Syndrome or of non-hepatic cause)
Total bilirubin < . ULN. Subjects with a known history of Gilberts Disease and an isolated elevation of indirect bilirubin are eligible.
Total bilirubin =< . x ULN (patients with Gilberts syndrome may have serum bilirubin > . x ULN)
Total bilirubin ? ULN (except in patients who have Gilberts syndrome or patients with recently placed stents for biliary obstruction when bilirubin should be < . X ULN) obtained ?  days prior to randomization
Direct bilirubin (bili) =< % if total bili > ULN in patients with Gilberts syndrome
Total bilirubin =< . x ULN (except if the patient has Gilberts syndrome who can have total bilirubin =<  x ULN) must be met during screening (within  days) and also prior to study drug administration on cycle  day 
Total bilirubin =<. X institutional ULN (or =<  X institutional ULN for patients with documented Gilberts syndrome) (unless dysfunction is secondary to lymphoma involvement)
Total bilirubin =< . x ULN (In the expansion cohort, subjects with Gilberts syndrome [hereditary indirect hyperbilirubinemia] who must have a total bilirubin of =<  x ULN).
Total bilirubin ? . x ULN (AST, ALT, and total bilirubin ?   ULN in subjects with documented Gilberts syndrome or hyperbilirubinemia clearly attributed to lymphoma involvement of the liver)
ALT, AST > . ULN or total bilirubin > . ULN (not attributable to Gilberts)
Subjects with Gilberts syndrome, confirmed by genotyping or Invader UGTIA molecular assay prior to study entry, must have total bilirubin < . times ULN
Total bilirubin > or = . x ULN, unless due to Gilberts disease.
Bilirubin =< . x ULN; for subjects with documented/suspected Gilberts disease, bilirubin =<  x ULN
Total serum bilirubin =< . x ULN (except if Gilberts disease)
Bilirubin =< . x ULN (exceptions for Gilberts syndrome)
Within  days prior to registration: Total bilirubin =< . x ULN (except in patients with Gilberts disease)
Total bilirubin =<  x ULN (except patients with documented Gilberts syndrome)
PHASE II SCLC: Total bilirubin =< . x ULN (unless Gilberts disease)
UROTHELIAL CARCINOMA EXPANSION COHORT: Total bilirubin =< . x ULN (=<  x ULN for subjects with Gilberts disease)
mCRPC EXPANSION COHORT: Total bilirubin =< . x ULN (=<  x ULN for subjects with Gilberts disease)
Total serum bilirubin ? . x ULN (? . x ULN if Gilberts disease)
Total bilirubin >  x institutional ULN (except for known Gilberts syndrome/familial non-hemolytic jaundice)
PHASE II COLORECTAL CANCER COHORT  (MEDI+C ONLY):\r\nTotal bilirubin =< . X ULN; for subjects with documented/suspected Gilberts disease, bilirubin =<  X ULN
Total serum bilirubin =< . x ULN (=<  x ULN for Gilberts syndrome)
Bilirubin =< . x ULN or =<  x ULN for subjects with documented/suspected Gilberts disease
Direct bilirubin < . (unless related to Gilberts disease or medications)
Total bilirubin =< . x ULN for the laboratory (total bilirubin criteria may be waived if a patient has documented Gilberts disease)
Bilirubin =<  unless consistent with Gilberts (total/direct > )
Total bilirubin ? . x ULN (excepting Gilberts syndrome)
Within  days of first dose of study drug: Bilirubin =< . x ULN (<  x ULN if hyperbilirubinemia is due to Gilberts syndrome)
Bilirubin must be =< . x ULN, except participants with Gilberts syndrome where bilirubin must be =< . x ULN
BLADDER: Clinical laboratory values at screening: bilirubin ? . x the ULN; for subjects with known Gilberts disease, bilirubin ? . mg/dL
Total bilirubin =< . x ULN; if liver metastases or metabolic disorder such as Gilberts syndrome, then =< . x ULN
Total bilirubin =< . x ULN for the laboratory; Note: Patients with known Gilberts syndrome are not eligible for this study
Total bilirubin =< . x ULN unless if evidence of indirect hyperbilirubinemia due to for example Gilberts syndrome
Total bilirubin =< . x ULN (patients with Gilberts syndrome may have serum bilirubin > . ULN)
Total bilirubin =< . x ULN unless Gilberts syndrome of disease infiltration of the liver is present
Total bilirubin (TBil) and direct bilirubin (DBil) =< ULN with an exception of patients with confirmed Gilberts syndrome; for patients with confirmed Gilberts syndrome, the TBil should be =< . x ULN
Total bilirubin =< . x ULN for the laboratory (total bilirubin criteria may be waived if a subject has documented Gilberts syndrome)
Total bilirubin within . x ULN, except those with Gilberts syndrome for whom this must be < x ULN
Bilirubin =< . x ULN within  days prior to study registration; unless patient has Gilberts disease
Total bilirubin < . x ULN unless the patient has Gilberts syndrome, in which case total (T) bilirubin < . x ULN required
Total bilirubin =<  x ULN (except patients with documented Gilberts syndrome)
Bilirubin =< . x ULN OR in subjects with Gilberts syndrome, a total bilirubin =< . x ULN
Total-value bilirubin (TBil) and direct bilirubin (DBil) =< ULN with an exception of patients with confirmed Gilberts syndrome; for patients with confirmed Gilberts syndrome, the TBil should be =< . x ULN
Obtained =<  days prior to registration:\r\nTotal bilirubin =< . x ULN (does not apply to patients with isolated hyperbilirubinemia [e.g., Gilberts disease], in that case direct bilirubin should be =<  x ULN)
Serum bilirubin =< . x ULN (except patients with Gilberts syndrome who must have a total bilirubin of <  times ULN)
Total serum bilirubin =< . x ULN; patients with Gilberts syndrome with baseline serum bilirubin exceeding this limit are allowed to participate
Bilirubin < . x ULN, unless subject has Gilberts disease
Bilirubin must not be more than . x ULN (does not apply to patients with Gilberts disease)
Total bilirubin =< ULN (patients with Gilberts syndrome are eligible, even if total bilirubin is > ULN)
Bilirubin >=  x ULN (unless Gilberts syndrome)
Obtained =<  days prior to registration: Total bilirubin =< . x ULN (does not apply to patients with isolated hyperbilirubinemia [e.g., Gilberts disease], in that case direct bilirubin should be =<  x ULN)
Total bilirubin =< . X ULN; patients with increased bilirubin due to Gilberts disease will not be excluded, if increased bilirubin is the only protocol exclusion criteria met
Total bilirubin =<. x ULN unless increase is due to Gilberts disease or similar syndrome involving slow conjugation of bilirubin
Total bilirubin =< . x ULN (< . x ULN in the presence of Gilberts disease)
Bilirubin =< . x ULN, except in cases of patients with Gilberts disease, where =<  x ULN will be allowed
Total bilirubin =< . x ULN, unless elevated bilirubin is attributable to Gilberts syndrome or to HIV medications (e.g., indinavir, tenofovir, atazanavir)
Bilirubin =< . ULN (subjects with documented diagnosis of Gilberts syndrome are eligible provided total bilirubin < . x ULN)
Total bilirubin =<  x ULN, or <  ULN if Gilberts disease
Total bilirubin =< , unless due to Gilberts disease
Total bilirubin =<  x ULN (in the expansion cohort, patients with Gilberts syndrome [hereditary indirect hyperbilirubinemia] who must have a total bilirubin of =<  x ULN)
Bilirubin < . x ULN (unless Gilberts is suspected in which case total bilirubin <  x ULN)
Total serum bilirubin =< . x ULN (if documented Gilberts syndrome =<  x ULN) obtained =<  days prior to registration
Total bilirubin < . x ULN (if thought to be > . x ULN due to Gilberts disease or the patients AML, must discuss with the principal investigator [PI])
Serum bilirubin =< . x ULN or LLN (except for patients with Gilberts disease)
Greater than  x the ULN for total bilirubin (except for known cases of Gilberts syndrome, where the levels of conjugated bilirubin must be less than  x the ULN)